ROSELLE CALYX (HIBISCUS SABDARIFFA. L) AS AN ANTI-DIABETIC: ETHYL ACETATE FRACTION REDUCE FASTING BLOOD GLUCOSE TOTAL CHOLESTEROL AND REPAIR PANCREAS FUNCTION ON DIABETIC MODEL

NETTY SUHARTI; ARMENIA ARMENIA; RAHMAD ABDILLAH; CYNDI MURIA RAMADAN

doi:10.22159/ijap.2024.v16s1.25

Authors

NETTY SUHARTI Departement of Pharmaceutical Biology and Natural Product, Faculty of Pharmacy, Universitas Andalas, Limau Manis-25163, Padang, West Sumatera, Indonesia https://orcid.org/0000-0001-9072-2522
ARMENIA ARMENIA Departement of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Andalas, Limau Manis-25163, Padang, West Sumatera, Indonesia https://orcid.org/0000-0001-9072-2522
RAHMAD ABDILLAH Departement of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Andalas, Limau Manis-25163, Padang, West Sumatera, Indonesia https://orcid.org/0000-0001-9072-2522
CYNDI MURIA RAMADAN Undergraduate Pharmacy Study Programme Faculty of Pharmacy, Universitas Andalas, Limau Manis-25163, Padang, West Sumatera, Indonesia

DOI:

https://doi.org/10.22159/ijap.2024.v16s1.25

Keywords:

Antioxidant, Blood glucose, Hibiscus sabdariffa, Total cholesterol, Triglycerides, Histopathology

Abstract

Objective: In general, people with diabetes mellitus will experience disturbances in fat metabolism that lead to hypercholesterolemia. This study aims to determine the effect of ethyl acetate fraction hibiscus calyx on blood sugar, blood cholesterol level, and pancreas histology in diabetic Wistar Kyoto rats induced by streptozotocin.

Methods: Thirty-six Wistar Kyoto rats were induced with intra-peritoneal streptozotocin at 55 mg/kg BW and stabilized for five days to obtain diabetic conditions. Diabetic animals were divided into four groups; the diabetic group was given vehicle, the glibenclamide group was given 0.45 mg/kg BW of Glibenclamide, and two groups were administered the ethyl acetate fraction of hibiscus calyxes (EAFHC) at doses of 100 mg/kg BW and 200 mg/kg BW for five days. Fasting blood sugar and lipids (total cholesterol and triglycerides) were measured on days 0, 1, 3, and 5. Pancreats were collected on days 1, 3 and 5 for weighing and histology examination. All data were analyzed using two-way ANOVA followed by the Duncan Multiple Rank Test (DMRT).

Results: EAFHC significantly reduced fasting blood sugar and total cholesterol (p<0.05) but did not have a significant effect on triglycerides (p>0.05). Histology examination showed that EAFHC repaired pancreatic damage, as seen from the decrease in pancreatic histology scores (p<0.05), but the organ ratio did not show a significant improvement (p>0.1).

Conclusion: This study revealed that EAFHC could be an alternative medicine in managing blood sugar levels and total cholesterol and improving pancreas function in associated models of diabetes mellitus hypercholesterolemia complications.

Downloads

Download data is not yet available.

References

Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022 Jan;183:109-19. doi: 10.1016/j.diabres.2021.109119.

Pasupuleti VR, Arigela CS, Gan SH, Salam SKN, Krishnan KT, Rahman NA. A review on oxidative stress, diabetic complications, and the roles of honey polyphenols. Oxid Med Cell Longev. 2020;2020:8878172. doi: 10.1155/2020/8878172, PMID 33299532.

Becker DE. Basic and clinical pharmacology of glucocorticosteroids. Anesth Prog. 2013;60(1):25-32. doi: 10.2344/0003-3006-60.1.25, PMID 23506281.

Rad SK, Arya A, Karimian H, Madhavan P, Rizwan F, Koshy S. Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease. Drug Des Dev Ther. 2018;12:3999-4021.

Joshi SR, Standl E, Tong N, Shah P, Kalra S, Rathod R. Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review. Expert Opin Pharmacother. 2015;16(13):1959-81. doi: 10.1517/14656566.2015.1070827.

Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001;34(7):583-8. doi: 10.1016/s0009-9120(01)00263-6, PMID 11738396.

Frijhoff J, Winyard PG, Zarkovic N, Davies SS, Stocker R, Cheng D. Clinical relevance of biomarkers of oxidative stress. Antioxid Redox Signal. 2015;23(14):1144-70. doi: 10.1089/ars.2015.6317.

Sowers JR. Recommendations for special populations: diabetes mellitus and metabolic syndrome. Am J Hypertens. 2003;16(11 Pt 2):41S-5S. doi: 10.1016/j.amjhyper.2003.07.009, PMID 14625160.

Tan BKH, Tan CH, Pushparaj PN. Anti-diabetic activity of the semi-purified fractions of averrhoa bilimbi in high-fat diet fed-streptozotocin-induced diabetic rats. Life Sci. 2005;76(24):2827-39. doi: 10.1016/j.lfs.2004.10.051, PMID 15808883.

Widiyarti G, Sundowo A, Hanafi M, The free radical scavenging and anti-hyperglycemic activities of various gambiers available in Indonesian market. Makara Sci Ser. 2012;15(2):129-34.

Washington IM, Van Hoosier G, Marrow B, Marrow B, Marrow B, Marrow B. Clinical biochemistry and hematology. In: Washington IM, Van Hoosier G, editors. Clinical biochemistry and hematology. 2nd ed. Washington; 2012. p. 57-116.

Jones Muhammad M, Warrington JP. When high-fat diet plus hypertension does not equal vascular dysfunction. American Journal of Physiology-Heart and Circulatory Physiology. 2021;321(1):H128-30. doi: 10.1152/ajpheart.00284.2021.

Jamrozik D, Borymska W, Kaczmarczyk Zebrowska I. Hibiscus sabdariffa in diabetes prevention and treatment-does it work? An evidence-based review. Foods. 2022;11(14). doi: 10.3390/foods11142134.

Naseri R, Farzaei F, Haratipour P, Nabavi SF, Habtemariam S, Farzaei MH. Anthocyanins in the management of metabolic syndrome: a pharmacological and biopharmaceutical review. Front Pharmacol. 2018 Dec 4;9:1310. doi: 10.3389/fphar.2018.01310, PMID 30564116.

Sapian S, Ibrahim Mze AA, Jubaidi FF, Mohd Nor NA, Taib IS, Abd Hamid Z. Therapeutic potential of hibiscus sabdariffa linn. in attenuating cardiovascular risk factors. Pharmaceuticals. 2023;16(6):1-25.

Juwita DA, Farinka R, Abdillah R, Rachmaini F. Blood pressure lowering effects of vernonia amygdalina del. Aqueous fraction on hypertensive wistar kyoto rats. J Complement Integr Med. 2023;20(4):740-7. doi: 10.1515/jcim-2022-0416.

Armenia A, Wahyuni FS, Almahdy A, Abdillah R, Aquista PG, Putri DP. Blood pressure and blood sugar-lowering effects of purified gambir on diabetic hypertensive wistar kyoto rats. J Complement Integr Med. 2022;19(3):627-36. doi: 10.1515/jcim-2022-0054, PMID 35446514.

Armenia A, Hidayat R, Meiliani M, Yuliandra Y. Blood pressure lowering effect of scopoletin on oxidative stress-associated hypertensive rats. Marmara Pharm J. 2019;23(2):249-58.

Abdillah R, Fauziah F, Lestari PP, Rachmaini F. The cholesterol-lowering activity of averrhoa bilimbi l. leaves ethyl acetate fraction in hypercholesterolemic model. Pharmaciana. 2022;12(1):31-8. doi: 10.12928/pharmaciana.v12i1.19667.

Afriwardi AA, Abdillah R, Husni E, Hardini H, Syahbani Zuler KT, Alianta AA. Subacute toxicity test of hydrocotyle sibthorpioides lam. extract on histopathological images of liver and kidney of white male mice. Pharmacogn J. 2022;14(5):619-26. doi: 10.5530/pj.2022.14.144.

Muslim Z, Farizal J, Abdillah R, Sunita S. Effect of cnidoscolus aconitifolius extract on rat liver injury induced with carbon tetrachloride (CCl4). Trop J Nat. Prod Res. 2022;6(11):1809-13.

Abdo BM. Anthocyanin determination of ethiopian roselle (Hibiscus sabdariffa) genotypes. Nat Prod Chem Res. 2022;10(6):1-4.

Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother. 2005 Aug;59(7):365-73. doi: 10.1016/j.biopha.2005.07.002.

Mattioli R, Francioso A, Mosca L, Silva P. Anthocyanins: a comprehensive review of their chemical properties and health effects on cardiovascular and neurodegenerative diseases. Molecules. 2020 Aug 21;25(17):3809. doi: 10.3390/molecules25173809, PMID 32825684.

Mostafavinia A, Amini A, Ghorishi SK, Pouriran R, Bayat M. The effects of dosage and the routes of administrations of streptozotocin and alloxan on induction rate of type1 diabetes mellitus and mortality rate in rats. Lab Anim Res. 2016;32(3):160-5. doi: 10.5625/lar.2016.32.3.160, PMID 27729932.

Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis. 2005;15(4):316-28. doi: 10.1016/j.numecd.2005.05.003, PMID 16054557.

Manzano Pech L, Guarner Lans V, Elena Soto M, Diaz Diaz E, Perez Torres I. Alteration of the aortic vascular reactivity associated to excessive consumption of Hibiscus sabdariffa linnaeus: preliminary findings. Heliyon. 2023;9(9):e20020. doi: 10.1016/j.heliyon.2023.e20020.

Calle MC, Fernandez ML. Inflammation and type 2 diabetes. Diabetes Metab. 2012;38(3):183-91. doi: 10.1016/j.diabet.2011.11.006, PMID 22252015.

Taha DA, Wasan EK, Wasan KM, Gershkovich P. Lipid-lowering activity of natural and semi-synthetic sterols and stanols. J Pharm Pharm Sci. 2015;18(4):344-67. doi: 10.18433/j3gc84, PMID 26626241.

Laka K, Makgoo L, Mbita Z. Cholesterol-lowering phytochemicals: targeting the mevalonate pathway for anticancer interventions. Front Genet. 2022;13(Mar):841639. doi: 10.3389/fgene.2022.841639, PMID 35391801.